
Peanut Allergy Skin Patch Desensitizes Toddlers with Immunotherapy
A skin patch to combat peanut allergies in children under the age of 4 has shown to be safe and more effective than placebo in a "landmark" phase III trial. The patch works like exposure therapy, slowly training the toddlers' bodies to tolerate proteins in peanuts that may cause an immune response in normal cases. By the end of the 12-month study, 67% of the children didn't experience adverse reactions to peanuts, double that of the placebo group. The trial is the first to demonstrate the safety and efficacy of a treatment for children under the age of 4.





